In 2015, I discovered my cholesterol levels were rising, my APOB was high-risk, and I was prediabetic. I also carried the APOE4 allele, a risk factor for Alzheimer’s, and was a hyper-absorber of cholesterol. By 2020, post-menopause, my numbers had doubled, and in 2022, I learned I was also a hyposynthesizer, meaning my body now overproduced cholesterol. Despite a lifelong healthy lifestyle, I faced an uphill battle.
If this sounds confusing, stay with me—today’s episode is about screening and solutions for preventing heart disease during menopause and beyond - still the #1 killer of women. The internet is full of conflicting and fear-mongering guidance when it comes to women's heart disease risk and prevention. This episode will gift you with the current science on:
-Women's Health Initiative findings on heart disease and hormone therapy
-Estrogen's protective effects on the heart and whole body
-What lab biomarkers are essential to assessing risk
-What is the Cholesterol Balance Test?
-Statin therapy options
-Should you get a CAC Scan (coronary calcium score)
My special guest, Dr. Thomas Dayspring, is a leading expert in lipidology and women’s cardiovascular health. A renowned educator and clinician, he has given over 4,000 lectures, authored lipid textbook chapters, and is a trusted voice in cardiovascular medicine. His expertise will help midlife women navigate heart disease risk with science-backed insights and practical solutions.
Read More